Results 251 to 260 of about 8,209,000 (311)
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura +19 more
wiley +1 more source
Differences in Income Growth Between People With Multiple Sclerosis and Controls: A Norwegian Cohort Study. [PDF]
Høgset A +6 more
europepmc +1 more source
Spatiotemporal localization of sex difference in plantar pressure distribution during self paced walking in healthy Japanese adults. [PDF]
Doi H, Furuta N, Yoon H, Funato K.
europepmc +1 more source
Simulation Study on Dielectric Constant Sensing by Interference of Spoof Surface Plasmon Polaritons. [PDF]
Zeng T, Bi C, Zhou J, Gong S.
europepmc +1 more source
The Contribution of Chemistry to the Detection and Enumeration of Legionella pneumophila in Environmental Water Samples: Experience With the MICA Method. [PDF]
Ditommaso S +6 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Generalized Difference-in-Differences
Epidemiology, 2022Difference-in-differences (DID) analyses are used in a variety of research areas as a strategy for estimating the causal effect of a policy, program, intervention, or environmental hazard (hereafter, treatment). The approach offers a strategy for estimating the causal effect of a treatment using observational (i.e., nonrandomized) data in which ...
David B. Richardson +2 more
openaire +2 more sources

